Deutsche Bank
OPNT

Deutsche Bank’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Deutsche Bank’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-675
Closed -$9K – 4999
2019
Q4 		$9K Sell
675
-677
-50% -$9.87K ﹤0.01% 4540
2019
Q3 		$20K Buy
+1,352
New +$18.8K ﹤0.01% 4329
2018
Q1 		– Sell
-100
Closed -$2K – 5673
2017
Q4 		$2K Buy
+100
New +$3.2K ﹤0.01% 4923

Other funds holding OPNT

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank's OPNT Position: Q1 2020 in Review

Deutsche Bank sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2020, closing a stake of 675 shares — an estimated $9K sold.

Deutsche Bank first reported a position in OPNT in Q4 2017 and held it in 3 quarters. The position peaked at $20K in Q3 2019. 31 funds tracked by Wall St. Rank hold OPNT as of Q1 2020.

  • Deutsche Bank reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 675 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $9K.
  • Deutsche Bank first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Deutsche Bank's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $20K in Q3 2019.
  • 31 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.